Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4562 Secondary endpoint results of the first multicentric randomised phase II trial investigating the antitumour efficacy of 177Lutetium-DOTA-Octreotate (OCLU) in advanced progressive neuroendocrine pancreatic tumour: The OCLURANDOM trial

Introduction: No published randomised trial investing the role of PRRT (177Lutetium-DOTA-Octreotate) in advanced progressive PaNET patients.

Conference:

Presenting Author: Baudin E

Authors: Baudin E, Walter T, Beron A, Smith D, Deandreis D,

Keywords: Pancreatic neuroendocrine, randomised phase 2 trial, Lutathera, Sunitinib,

#4023 Empowering patients with neuroendocrine tumors through a mobile app: NETcare

Introduction: Patients with neuroendocrine tumors (NET) face unmet needs across various domains, encompassing treatment and symptom management. Addressing the diverse challenges requires a proactive multidisciplinary team and well-informed patients. The integration of mobile apps proves invaluable in maintaining comprehensive records of patients' experiences between medical appointments.

Conference:

Presenting Author: Martinezlago N

Authors: Martinez Lago N, Mancebo Cobos S, Reboredo Rendo C, Alonso de Castro B, Vazquez Ferreiro E,

Keywords: Neuroendocrine tumor, APP, empowerment,

#3534 Avelumab in unresectable/metastatic, progressive, grade 2-3 neuroendocrine neoplasms (NENs): Translational results from NET-001 and NET-002 trials

Introduction: The role of immunotherapy (IO) and predictive biomarkers in NENs patients remains unclear.

Conference:

Presenting Author: Rodriguez Freixinos V

Authors: Rodriguez-Freixinos V, Bruce J, Chan D, Nunez-Rodriguez J, Mackenzie D,

Keywords: neuroendocrine, cell, research, immunotherapy,

#3281 Prediction of progression-free survival in patients with neuroendocrine tumors received 177Lu-Dotatate using circulating biomarkers

Introduction: Few circulating biomarkers are available for prediction of progression-free survival (PFS) in patients with advanced neuroendocrine tumors (NET) received 177Lu-Dotatate.

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Chen L, Gnanasegaran G, Mandair D, Toumpanakis C, Caplin M,

Keywords: PRRT, survival, ESR, creatinine, CgA,

#2254 Development of a Patient-Centred Service for Neuroendocrine Tumors (NETs) in Wales: Population Based National Commissioning

Introduction: Requiring many specialities and services, NETs have complex pathways presenting a challenge to plan services in existing NHS structures

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Khan M, Reynolds M, Lewis J, Bell C, Rees A,

Keywords: Service, commissioning, Mdt,